A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands

被引：0
|
作者：
Gericke, Germo [1 ]
机构：
[1] Novartis Co, Adv Accelerator Applicat, CH-1204 Geneva, Switzerland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / 09期
关键词：
1;
D O I：
10.1007/s00259-021-05400-5
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：2666 / 2667
页数：2
相关论文
共 50 条
  • [1] A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands
    Germo Gericke
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2666 - 2667
  • [2] EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)
    Clemens Kratochwil
    Wolfgang Peter Fendler
    Matthias Eiber
    Richard Baum
    Murat Fani Bozkurt
    Johannes Czernin
    Roberto C. Delgado Bolton
    Samer Ezziddin
    Flavio Forrer
    Rodney J. Hicks
    Thomas A. Hope
    Levant Kabasakal
    Mark Konijnenberg
    Klaus Kopka
    Michael Lassmann
    Felix M. Mottaghy
    Wim Oyen
    Kambiz Rahbar
    Heiko Schöder
    Irene Virgolini
    Hans-Jürgen Wester
    Lisa Bodei
    Stefano Fanti
    Uwe Haberkorn
    Ken Herrmann
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 2536 - 2544
  • [3] EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)
    Kratochwil, Clemens
    Fendler, Wolfgang Peter
    Eiber, Matthias
    Baum, Richard
    Bozkurt, Murat Fani
    Czernin, Johannes
    Delgado Bolton, Roberto C.
    Ezziddin, Samer
    Forrer, Flavio
    Hicks, Rodney J.
    Hope, Thomas A.
    Kabasakal, Levant
    Konijnenberg, Mark
    Kopka, Klaus
    Lassmann, Michael
    Mottaghy, Felix M.
    Oyen, Wim
    Rahbar, Kambiz
    Schoder, Heiko
    Virgolini, Irene
    Wester, Hans-Juergen
    Bodei, Lisa
    Fanti, Stefano
    Haberkorn, Uwe
    Herrmann, Ken
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (12) : 2536 - 2544
  • [4] 2021: the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
    Ken Herrmann
    Clemens Kratochwil
    Wolfgang P. Fendler
    Matthias Eiber
    Roland Hustinx
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2668 - 2669
  • [5] 2021: the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? Reply to "A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands" by Dr. Germo Gericke
    Herrmann, Ken
    Kratochwil, Clemens
    Fendler, Wolfgang P.
    Eiber, Matthias
    Hustinx, Roland
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (09) : 2668 - 2669
  • [6] EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
    Gleisner, Katarina Sjogreen
    Chouin, Nicolas
    Minguez Gabina, Pablo
    Cicone, Francesco
    Gnesin, Silvano
    Stokke, Caroline
    Konijnenberg, Mark
    Cremonesi, Marta
    Verburg, Frederik A.
    Bernhardt, Peter
    Eberlein, Uta
    Gear, Jonathan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (06) : 1778 - 1809
  • [7] EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
    Katarina Sjögreen Gleisner
    Nicolas Chouin
    Pablo Minguez Gabina
    Francesco Cicone
    Silvano Gnesin
    Caroline Stokke
    Mark Konijnenberg
    Marta Cremonesi
    Frederik A. Verburg
    Peter Bernhardt
    Uta Eberlein
    Jonathan Gear
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 1778 - 1809
  • [8] The effect of the total tumour volume on the kidneys, salivary glands and tumour BEDs for 177Lu-labelled PSMA ligands
    Begum, N. J.
    Thieme, A.
    Allmann, J.
    Eiber, M.
    Beer, A. J.
    Glatting, G.
    Kletting, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S271 - S271
  • [9] The efficacy of 177Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumours: a meta-analysis
    Kim, Seong-Jang
    Pak, Kyoungjune
    Koo, Phillip J.
    Kwak, Jennifer J.
    Chang, Samuel
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (13) : 1964 - 1970
  • [10] The efficacy of 177Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumours: a meta-analysis
    Seong-Jang Kim
    Kyoungjune Pak
    Phillip J. Koo
    Jennifer J. Kwak
    Samuel Chang
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1964 - 1970
12345